Natural Biocon (India) Ltd

Natural Biocon (India) Ltd has announced the closure of its trading window for designated persons and their immediate relatives. This restriction, effective from July 1, 2026, will remain in place until 48 hours after the declaration of the company's unaudited financial results for the quarter ended June 30, 2026. The closure is mandated by SEBI's Insider Trading Regulations, 2015, and the company's internal code. The date for the Board Meeting to approve these results will be announced later.

Natural Biocon (India) Ltd announced outcomes from its Board Meeting held on June 6, 2026. Key decisions include ratifying resolutions from an extraordinary general meeting, approving the Director's Report and Secretarial Audit Report for FY26, and setting the 34th Annual General Meeting (AGM) for July 4, 2026. The company also appointed Mrs. Tapasya Sheth and Mrs. Minaben Shah as Additional Directors (Non-Executive Independent Directors) and accepted the resignation of Mr. Gopal Trivedi as Company Secretary. The Register of Members and Share Transfer Books will be closed from June 28 to July 4, 2026, for the AGM.

Natural Biocon (India) Ltd. has announced that its Board of Directors will convene on June 6, 2026. The meeting's agenda includes several key items related to the upcoming Annual General Meeting (AGM). The board will consider and approve the ratification of resolutions passed at the Extra-ordinary General Meeting held on May 23, 2024. Furthermore, they will review and approve the draft Director's Report and Secretarial Audit Report for the financial year ended March 31, 2026. Critical decisions will also be made regarding the AGM, including fixing its day, date, time, and venue, as well as determining the book closure dates for share transfer purposes. The board will also approve the draft notice for the AGM and appoint a scrutinizer for the e-voting process and voting at the meeting. This meeting is essential for ensuring compliance and preparing for shareholder engagement.

Natural Biocon (India) Limited announced that its Board of Directors meeting, originally scheduled for May 18, 2026, could not be held. The meeting was intended to consider and approve the Director's Report, Secretarial Audit Report, and other administrative matters related to the upcoming Annual General Meeting. The postponement was due to an unexpected and unavoidable medical emergency involving the Managing Director, whose presence was deemed essential for the agenda items. The company has rescheduled the Board Meeting for June 06, 2026, to address the previously listed items.

Natural Biocon (India) Ltd has scheduled a Board of Directors meeting on May 18, 2026, to consider and approve the Annual General Meeting (AGM) and other related matters. The meeting will address the ratification of resolutions passed at the extra ordinary general meeting held on May 23, 2024, and approve the draft of the Director's Report and Secretarial Audit Report for the year ended March 31, 2026.

Natural Biocon (India) Ltd has announced its audited financial results for the quarter and year ended March 31, 2026. The Board of Directors approved the standalone audited financial results in a meeting held on May 09, 2026. The results have been reviewed by the Audit Committee and audited by M/s Mayur Shah & Associates, Chartered Accountants, who issued an audit report with an unmodified opinion. The board meeting commenced at 05:00 p.m. and concluded at 06:45 p.m.

Natural Biocon (India) Ltd has announced its audited financial results for the quarter and year ended March 31, 2026. The Board of Directors approved the standalone results in a meeting held on May 09, 2026. The results, along with the auditor's report by M/s Mayur Shah & Associates, have been reviewed by the Audit Committee. The auditors issued an unmodified opinion on the standalone financial results. The company has also disclosed details on outstanding defaults on loans and debt securities, which are reported as ₹0.

Natural Biocon (India) Ltd has announced the postponement and rescheduling of its Board of Directors meeting. Originally set for April 30, 2026, the meeting will now take place on Saturday, May 9, 2026. The primary agenda for this meeting remains the consideration and approval of the Audited Financial Results along with the Auditor's Report and Certificate for unmodified opinion for the quarter and financial year ended March 31, 2026.

Natural Biocon (India) Ltd has scheduled a Board of Directors meeting on April 30, 2026, to consider and approve the Audited Financial Results for the quarter and financial year ended March 31, 2026. The meeting will also address any other business with the Chairman's permission. This is pursuant to Regulation 29 and 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015.

Natural Biocon (India) Ltd has announced the closure of its trading window for dealing in the securities of the company by promoters, members of the promoter group, directors, key managerial persons (KMPs), insiders, designated and connected persons, and their immediate relatives. The closure is from Wednesday, April 1, 2026, till 48 hours after the declaration of its financial results for the quarter and year ended March 31, 2026. This move is in accordance with the provisions of the Clause 4(2) of Schedule B read with Regulation 9 of Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, SEBI Circular No. SEBI/HO/ISD/ISD-SEC-4/P/CIR/2022/107 dated August 5, 2022, and SEBI/HO/ISD/ISD-PoD-2/P/CIR/2023/124 dated July 19, 2023. The date of the board meeting in connection with publishing its financial results for the quarter and year ended March 31, 2026, will be announced in due course.